Summary
The LD,, of aminophylline in adult mice differed from young mice and rats of both ages, in which the values were remarkably similar ( Table 1) . With the exception of fat, which had lower concentrations in all groups, tissue concentrations after a 4 mgl kg rectal dose of aminophylline in the 10-day-old animals ranged from 10-20 pglg as compared to 4-10 pglg in the adults ( Table  2) . T o evaluate preferential distribution, an analysis of tissue to blood concentration ratios was made. All ratios approximated 1.0 except fat which had a ratio of 0.1-0.6. The neonates of each species had significantly higher tissue to blood ratios for brain, heart, small intestine, skeletal muscle, and fat ( P < 0.05). Brain to plasma and brain to blood ratios were very similar ranging from 0.4-1.3 in adults versus 0.8-1.7 in neonates. Consideration of the time course indicated a trend toward unit, with the overall ratio in both groups being 1.15 at 2 hr. However, at all earlier time periods the ratios were clearly higher in neonates.
--~dministratibn of aminophylline intraperitoneally to produce serum concentrations of theo~hvlline far in excess of the 10-20 pglml considered to be safe a n i effective in clinical use did not decrease bilirubin levels in young or old Gunn rats (Fig. 1) .
INTRODUCTION
The treatment of apnea of prematurity with aminophylline (2.14.27.32) introduces questions regarding the pharmacology of the drug in immature patients. Previous measurements of elimination (serum half-lives for the beta-phase) have established differences among individuals and between age groups. While mean half-lives for adults and children average 4.5 hours (22) and 3.5 hours (18). respectively, recent measurements in premature infants average ca. 24 hours (1.7.23).
Alterations in distribution secondary to imaturity may also contribute to age-related differences in toxicity. Such a change may be extremely important for a drug such as theophylline, which is known to exhibit significant central nervous system (CNS) toxicity in clinical use. For example. irritability and seizures have been reported in children and adults associated with high doses and elevated serum levels (25.29.35).
Despite widespread use of aminophylline for over forty years (19). developmental studies in animals are lacking. Acute toxicity has been determined in mice and rabbits (8.13.20.31).
tissue distribution studied in rabbits (26) and blood-CSF ratios reported for the dog (30). None of these studies involved immature animals.
The purpose of this investigation was to study the acute toxicity end tissue distribution of aminophylline. emphasizing the b1ood:brain ratio in young and older rodents. Since the rectal route of administration has been employed clinically (2,141, it was included in the acute toxicity experiments and used for all groups in the distribution experiments. For adequate retention of the rectal solution, the young animals had to be at least ten days old. Mice and rats were used since brain myelination is delayed in these animals and resembles the preterm human (10.33).
As hyperbilirubinemia is common in premature infants. an fi viva assessment of the ability of theophylline to displace bilirubin from serum binding sites was studied in young and old jaundiced Gunn rats (9). 17) found no metabolism of theophylline in the brain, heart. lung, kidney, spleen, intestine, or adrenals of the rat. Moreover, the major liver metabolites were the oxidized products, 1-methyluric acid and 1.3-dimethyluric acid, which would not be included in our determination of radioactivity. In addition, minor metabolites which would retain the radiolabel, such as 3-methylxanthine. would not be expected to accumulate appreciably in the short time of the experiment (two hours).
MATERIALS

Blood-Brain Distribution.
Ten-day-old and adult mice were given a sublethal dose of aminophylline (50 mg/kg) per rectum (25 mglml with IHtheophylline 140 uCiIml. 2 ullg). and groups of ten were decapitated at 15, 30. 60. and 120 minutes. the brains dissected. weighed. solubilized. and radioactivity determined. Blood was collected in heparinized test tubes. ~adioactivity in aliquots of plasma was determined in a "scintillation cocktail" (16.5 g PPO. 0.3 g Dimethyl POPOP. 1 L Triton X-100, and 2 L toluene). Efficiency of counting was determined by internal standardization and the concentration of theophylline was calculated as described above.
Bilirubin Dis lacement. Aminophylline was administered i.p. to onem o n t h~m g / k~) and adult (100 mg/kg) homozygous Gunn rats. These animals suffer a genetically determined nonhemolytic unconjugated hyperbilirubinemia (11). Blood samples were taken from the tail vein at 0, 30, 60, 120, 180 minutes, and assayed for theophylline by radioimunoassay (23) and for bilirubin by the method of White, et 81. (34). As a positive control sulfisoxazole (100 mglkg i.p.). was administered to two adult Gunn rats.
Statistical Procedures. The acute toxicity data were analyzed by the methoa n d 1 (21). The percentage of deaths was converted to probits and plotted versus the logarithm of the dose. The LD and its standard error were determined graphically. The slopes and iBPercepts for the linear regression lines were compared using the technique of Snedecor and Cochran (28). except that differences were analyzed for all five lines instead of their two line model. The tissue concentrations and tissue:blood ratios were analyzed by Analysis of Variance using a factorial design. For each tissue the contributions to the variance from species, age, and time differences as well as the appropriate interactions were calculated.
RESULTS
Acute T E X~C~~Y .
Deaths of the ten-day-old animals of both species occurreb*it I" one hour of dosing. Untreated animals of this age were able to withstand at least four hours separation from their mothers without apparent ill effects. Deaths in the adult mice occurred within two hours of dosing, with no additional deaths occurring during a five day post-treatment observation period. In contrast. occasional additional deaths of adult rats occurred 12 -24 hours post-treatment. For this reason calculation of the LDS0 was based on deaths within the first two hours post-treatment.
Cause of death appeared to be central in origin, manifested by protrusion and biting of the tongue, tonic-clonic seizures, opisthotonus. rigidity, and cessation of respiration. Late deaths of adult rats appeared to have another basis. since they were flaccid and had no evidence of,tonguebiting.
The LD of aminophylline in adult mice differed from young mice and rats of botsOages, in which the values were remarkably similar (Table I) . Analysis of the regression line (probits vs. log-dose) of adult mice revealed that both its slope and intercept differed significantly (P < ,051 from those of the other four groups combined. Notably, the LDS0 in ten-day old mice was virtually the same when aminophylline was given rectally as when given i.p. (Table 1 (Table 11 ). While no statistically significant differences were found between time periods in any of the tissues, levels in the colon tended to be higher at 15 and 30 minutes than they were at one and two hours following rectal administration.
Species differences were found only in the heart and kidney. In both tissues, adult rats had significantly higher levels than did adult mice (P 0.05).
To evaluate preferential distribution, an analysis of tissue:blood concentration ratios was made. All ratios approximated one. except fat which had a ratio of 0.1 -0.6. The neonates of each species had significantly higher tissue:blood ratios for brain, heart, small intestine, skeletal muscle, end fat (P< 0.05).
The only tissue exhibiting a time dependency was fat where the ratios in at the first two time periods were significantly greater than in the last two in all groups except adult rats (P < 0.01).
Species differences were found in three tissues. In adults brain:blood ratios were higher in mice, whereas the reverse was found for the kidney: blood ratios (P < 0.05).
In the 10-day-olds. ratios for small intestine: blood were higher in mice (P < 0.05).
Blood-Brain Distribution. To further delineate the relative permeability of t h e i n barrier of the neonate vs that of the adult, the dose administered per rectum was increased from 4 to 50 mglkg. This 12.5-fold increase in dose resulted in plasma concentrations that were, in adults. only three-to four-fold greater than found in the previous experiment. In neonates only a two-to three-fold increase was found one and two-hours posttreatment (Table 111) 
DISCUSSION
The acute toxicity of aminophylline, expressed as the LDSO, from the ' present study in ten-day-old mice and in both ten-day-old and adult rats correlated well with those reported for adult rabbits (31). rats (41, and cats (8). The data, viewed collectively, suggest an LDS0 of ca. 175 mglkg i . . In contrast, a higher LDS0 (ca. 270 mgfkg) was found in adult mice in our study and in previous reports (6.12.13.19).
Thus the data indicate that one must not assume that an LDS0 will be lower for neonates than for adults, or merely make extrapolations from one species to another to estimate relative doses, since inconsistencies can be found even between species as closely related as mice and rats.
Excessive stimulation of the CNS by aminophylline appeared to be the cause of death in the rodents we studied. consistent with observations in higher mamalian species such as cats and dogs (13). Likewise, excessive CNS stimulation, manifested by hyperirritability and seizures, has been reported in man following aminophylline overdosage (29.35).
The clear differences in blood-brain distribution between ten-day-old and adult animals, while of interest, do not explain the age and species differences in LD50 The results do confirm that the so-called "blood-bmin barrier" is less developed in inmature mice and rats. Combining mean values at both doses and at all time periods yielded brain:blood ratios for neonatal of 1.2 vs 0.7 for adult mice and values of 0.7 vs 0.35 for imnature and adult rats. While this observation is compatible with and might be used to explain the age-related differences in LDS0 in mice, such reasoning cannot be applied universally, because rats did not exhibit an age-related difference in LD50.
Tissue concentrations of theophylline were consistently and significantly higher in ten-day-old animals of both species, but tissue:blood ratios approximated unity. This observation is important. having been demonstrated before only in two adult rabbits (26). for it provides an experimental basis for the use of serum and saliva theophylline concentrations for monitoring therapeutic and toxic effects. Calculated tissue compartment theophylline concentrations from a two-compartment pharmacokinetic model differ, and must be interpreted cautiously. Paalzow (24) found the tissue compartment theophylline concentrations to be 2.3 times the central compartment concentrations in rats, whereas Levy and Koysooko (16) Teschemacher, H.J., Ilerz, A.. Hess, R., Novoczek. G.: Permeation of purine derivatives into the cerebrospinal fluid of dogs. Experientia. The known binding of theophylline by serum proteins generates concern over bilirubin displacement. Aranda et al. (l) ,have shown by an ultracentrifugation method that 35% (at a serum concentration of 17 ug/ml) of theophylline was protein bound in the cord plasma of neonates versus 56% in adult plasma. In their study, theophylline (15 ug/ml) did not reduce bilirubin binding as determined by the Sephadex G-25 column technique. Similarly Brodersen (3). using the peroxidase method, found theophylline to be a very weak bilirubin displacer, causing a 5% displacement at 10 ug/ml. Our viva studies in Gunn rats agree with these in vitro findings and support the view that bilirubin displacement is uniiiikelyto present problems in the treatment of neonatal apnea with theophylline. 
CONCLUSlON
Our results in animals support the general clinical experience regarding the safety of the use of aminophylline in neonates. Ten-dayold rodents were not more sensitive than adults to its lethal effects. Although the LDS0 for newborn mice was less than that for adult mice, it was consistent wlth that found for adults of several other species, indicating that the adult mouse is unusually resistant to this drug. The uniform distribution of theophylline in body tissues supports the utility of serum theophylline levels in monitoring therapeutic and toxic effects and the analysis of such data by a one-compartment pharmacokinetic model. The relatively greater permeability of the neonatal blood-brain barrier necessitates careful observation and avoidance of excessive serum levels to avoid CNS toxicity. Since the site of action may be central respiratory chemoreceptors (5) . relatively low serum concentrations may be sufficient for a therapeutic effect. Thus, while at present there are no data available as to optimum serum levels in prematures, such levels may prove to be different from the 10 -20 uglml generally accepted as therapeutic and safe for treatment of bronchial asthma in children and adults.
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